Portland, OR -- (SBWire) -- 09/08/2017 --Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen, and cracked skin. The affected area may result in white fluid discharge and will require treatment. Atopic dermis usually begins in childhood and may get severe with age. The cause for atopic dermatitis involves genetic disorder, environmental exposure, immune system malfunctioning, and difficulty in the permeability of skin.
Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-toc-and-sample/3353
The atopic dermatitis treatment market is driven by factors such as launch of new products and a large patient population pool. However, factors such as stringent government regulations for product approval are expected to restrain the market growth. The development and advancements in healthcare in emerging countries are expected to offer new opportunities during the analysis period.
By mode of administration, the market is divided into topical, oral, and injectable. By distribution channel, the market is classified into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, mail order pharmacies, and dermatology clinics. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
- The study provides an in-depth analysis of the global atopic dermatitis treatment market, with current trends and future estimations to elucidate investment pockets.
- Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
- The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of different segments determines various products available in the market.
- Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.
Do purchase inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3353
Atopic Dermatitis Treatment Market Key Segments:
By Drug Class
- Corticosteroids
- Calcineurin Inhibitors
- Immunosuppressant
- Biologic Therapy
- PDE-4 Inhibitor
- Antibiotics
- Antihistamines
- Emollients
By Mode of Administration
- Topical
- Oral
- Injectable
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Mail Order Pharmacies
- Dermatology Clinics
By Geography
- North America
o U.S.
o Canada
o Mexico
- Europe
o UK
o Germany
o France
o Spain
o Italy
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
- LAMEA
o Latin America
o The Middle East
o Africa
List of players profiled in the report
- Sanofi SA
- Allergan Plc.
- Novartis International AG
- Bristol-Myers Squibb
- Bayer AG
- Meda Pharmaceuticals
- Anacor Pharmaceutical Inc.
- Pfizer
- Astellas Pharma Inc.
- Regeneron Pharmaceuticals
Atopic Dermatitis Treatment Market Industry Analysis and Forecast
The atopic dermatitis treatment market is segmented based on drug class, mode of administration, distribution channel, and geography. Based on drug class the market is segmented into Corticosteroids, Calcineurin Inhibitors, Immunosuppressant, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Antihistamines, and Emollients.